Khondrion receives EMA agreement on its Paediatric Investigation Plan for sonlicromanol

    NEXT STORY
    Immunotherapy Veteran Robert Knight, MD, Joins NexImmune as Chief Medical Officer
    PREV STORY
    Roche Annual General Meeting 2021: Exercising of shareholder rights via the independent proxy
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immune Design Reports Second Quarter 2017 Financial Results and Provides Corporate Update

    SEATTLE and SOUTH SAN FRANCISCO, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), ...

    author_avatar
    NASDAQ Market News

    AzurRx BioPharma and Mayoly Spindler Announce MS1819-SD Investigational Medicinal Product Dossier (IMPD) Submission

    BROOKLYN, N.Y., Oct. 20, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma Inc. (NASDAQ:AZRX) (“AzurRx” or ...

    author_avatar
    NASDAQ Market News

    NEOVACS Obtains South Korea Health Authority Approval for IND Application With IFNa Kinoid in Lupus

    PARIS, April 14, 2016 (GLOBE NEWSWIRE) -- NEOVACS (Alternext Paris:ALNEV), a leader in active ...

    author_avatar
    NASDAQ Market News